Clinical Trials Directory

Trials / Completed

CompletedNCT06427915

Studying Glucose and Appetite Response With Alternatives to Soda Pop

Studying GlucOse anD Appetite ResponseS With Alternatives to Pop (SODA-SWAP)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Olipop, PBC · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The primary aim of this clinical trial is to determine the acute effects of OLIPOP (a lower sugar, high fiber prebiotic soda) consumption, compared to consumption of a commercially available sugar-sweetened soda pop, on blood glucose in response to the beverages alone and in combination with a carbohydrate-rich mixed lunch meal in free-living, generally healthy adults.This study will consist of one screening/randomization clinic visit (day 0) and one follow-up clinic visit (day 5), with participants consuming study products on their own (e.g., at home) following an assigned treatment sequence on days 1, 2, 3, and 4. The main questions answered by this trial are the impacts of a prebiotic rich soda versus a traditional soda on: 1) blood glucose levels with and without a meal, 2) perceived hunger levels, 3) perceived alertness levels and 4) total caloric intake.

Conditions

Interventions

TypeNameDescription
OTHEROLIPOP prebiotic soda12oz serving containing Carbonated Water, OLISMART(TM) (Cassava Root Fiber, Acacia Fiber, Guar Fiber, Nopal Cactus\*, Marshmallow Root\*, Calendula Flower\*, Kudzu Root\*), Cassava Root Syrup, Apple Juice Concentrate, Lime Juice, Natural Cola Flavor, Alpinia Galanga Root\*, Stevia Leaf\*, Himalayan Pink Salt, Green Tea Caffeine\*, Natural Caramel Flavor, Natural Vanilla Flavor, Cinnamon\* (\*Extract)
OTHERTraditional sugar-sweetened cola12oz serving containing carbonated water, high fructose corn syrup, caramel color, phosphoric acid, natural flavors, caffeine

Timeline

Start date
2024-05-15
Primary completion
2024-06-21
Completion
2024-06-21
First posted
2024-05-24
Last updated
2025-04-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06427915. Inclusion in this directory is not an endorsement.